RXII Stock Quote
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Company Profile
SELLAS Life Sciences Group, Inc. engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S and ct-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.